Buscar

01/09/2022 The role of attentional control over interference in minor hallucinations in Parkinson's disease
Bejr-kasem, H, Martinez-Horta, S, Pagonabarraga, J, Marin-Lahoz, J, Horta-Barba, A, Sampedro, F, Aracil-Bolanos, I, Perez-Perez, J, Campolongo, A, Izquierdo, C, Pascual-Sedano, B, Kulisevsky, J. The role of attentional control over interference in minor hallucinations in Parkinson's disease. PARKINSONISM & RELATED DISORDERS. 2022; 102DOI:10.1016/j.parkreldis.2022.07.009. PMID:35987038. IF:4.100(Q2/3D).
01/08/2022 Post-COVID-19 fatigue: the contribution of cognitive and neuropsychiatric symptoms
Calabria, M, Garcia-Sanchez, C, Grunden, N, Pons, C, Arroyo, JA, Gomez-Anson, B, Garcia, MDE, Belvis, R, Morollon, N, Igual, JV, Mur, I, Pomar, V, Domingo, P. Post-COVID-19 fatigue: the contribution of cognitive and neuropsychiatric symptoms. JOURNAL OF NEUROLOGY. 2022; 269(8)DOI:10.1007/s00415-022-11141-8. PMID:35488918. IF:6.000(Q1/2D).
15/07/2022 Response to letter: "Association of elevated blood homocysteine with cognitive decline in early, untreated Parkinson's disease"
Sampedro F., Martínez-Horta S., Kulisevsky J.. Response to letter: "Association of elevated blood homocysteine with cognitive decline in early, untreated Parkinson's disease". JOURNAL OF THE NEUROLOGICAL SCIENCES. 2022; 438DOI:10.1016/j.jns.2022.120272. PMID:35576640. IF:4.400(Q2/3D).
02/06/2022 A Randomized Clinical Trial to Evaluate the Effects of Safinamide on Apathetic Non-demented Patients With Parkinson's Disease
Kulisevsky, J, Martinez-Horta, S, Campolongo, A, Pascual-Sedano, B, Marin-Lahoz, J, Bejr-kasem, H, Aracil-Bolanos, I, Horta-Barba, A, Puig-Davi, A, Pagonabarraga, J. A Randomized Clinical Trial to Evaluate the Effects of Safinamide on Apathetic Non-demented Patients With Parkinson's Disease. Frontiers in Neurology. 2022; 13DOI:10.3389/fneur.2022.866502. PMID:35720066. IF:3.400(Q2/5D).
01/06/2022 Predictors of the change in burden, strain, mood, and quality of life among caregivers of Parkinson's disease patients
Santos-Garcia, D, Fonticoba, TD, Bartolome, CC, Alvarado, MCI, Panceiras, MJF, Castro, ES, Canfield, H, Miro, CM, Jesus, S, Aguilar, M, Pastor, P, Planellas, L, Cosgaya, M, Caldentey, JG, Caballol, N, Legarda, I, Vara, JH, Cabo, I, Manzanares, LL, Aramburu, IG, Rivera, MAA, Mayordomo, VG, Nogueira, V, Puente, V, Garcia-Soto, JD, Borrue, C, Vila, BS, Sauco, MA, Vela, L, Escalante, S, Cubo, E, Padilla, FC, Castrillo, JCM, Alonso, PS, Losada, MGA, Ariztegui, NL, Gaston, I, Kulisevsky, J, Estrada, MB, Seijo, M, Martinez, JR, Valero, C, Kurtis, M, de Fabregues, O, Ardura, JG, Redondo, RA, Ordas, C, DiazL, LML, McAfee, D, Martinez-Martin, P, Mir, P. Predictors of the change in burden, strain, mood, and quality of life among caregivers of Parkinson's disease patients. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2022; 37(6)DOI:10.1002/gps.5761. PMID:35633051. IF:4.000(Q2/3D).
01/05/2022 Motor Fluctuations Development Is Associated with Non-Motor Symptoms Burden Progression in Parkinson's Disease Patients: A 2-Year Follow-Up Study
Santos-Garcia, D, Fonticoba, TD, Bartolome, CC, Painceiras, MJF, Castro, ES, Canfield, H, Miro, CM, Jesus, S, Aguilar, M, Pastor, P, Planellas, L, Cosgaya, M, Caldentey, JG, Caballol, N, Legarda, I, Hernandez-Vara, J, Cabo, I, Manzanares, LL, Aramburu, IG, Rivera, MAA, Mayordomo, VG, Nogueira, V, Puente, V, Garcia-Soto, JD, Borrue, C, Vila, BS, Sauco, MA, Vela, L, Escalante, S, Cubo, E, Padilla, FC, Castrillo, JCM, Alonso, PS, Losada, MGA, Ariztegui, NL, Gaston, I, Kulisevsky, J, Estrada, MB, Seijo, M, Martinez, JR, Valero, C, Kurtis, M, de Fabregues, O, Ardura, JG, Redondo, RA, Ordas, C, Diaz, LML, McAfee, D, Martinez-Martin, P, Mir, P. Motor Fluctuations Development Is Associated with Non-Motor Symptoms Burden Progression in Parkinson's Disease Patients: A 2-Year Follow-Up Study. Diagnostics. 2022; 12(5)DOI:10.3390/diagnostics12051147. PMID:35626303. IF:3.600(Q2/4D).
15/03/2022 Increased homocysteine levels correlate with cortical structural damage in Parkinson's disease
Sampedro, F, Martinez-Horta, S, Horta-Barba, A, Grothe, MJ, Labrador-Espinosa, MA, Jesus, S, Adarmes-Gomez, A, Carrillo, F, Puig-Davi, A, Lora, FR, Barbera, MA, Pastor, P, Arroyo, SE, Vila, BS, Foraster, AC, Martinez, JR, Padilla, FC, Morlans, MP, Aramburu, IG, Ceberio, JI, Vara, JH, de Fabregues-Boixar, O, de Deus Fonticoba, T, Avila, A, Martinez-Castrillo, JC, Bejr-Kasem, H, Campolongo, A, Pascual-Sedano, B, Martinez-Martin, P, Santos-Garcia, D, Mir, P, Kulisevsky, J. Increased homocysteine levels correlate with cortical structural damage in Parkinson's disease. JOURNAL OF THE NEUROLOGICAL SCIENCES. 2022; 434DOI:10.1016/j.jns.2022.120148. PMID:35085959. IF:4.400(Q2/3D).
01/01/2022 Apathy Reflects Extra-Striatal Dopaminergic Degeneration in de novo Parkinson's Disease
Sampedro, F, Martinez-Horta, S, Marin-Lahoz, J, Pagonabarraga, J, Kulisevsky, J. Apathy Reflects Extra-Striatal Dopaminergic Degeneration in de novo Parkinson's Disease. Journal of Parkinsons Disease. 2022; 12(5)DOI:10.3233/JPD-223223. PMID:35491803. IF:5.200(Q1/3D).
01/01/2022 A European Observational Study to Evaluate the Safety and the Effectiveness of Safinamide in Routine Clinical Practice: The SYNAPSES Trial (vol 11, pg 187, 2021)
Abbruzzese, G, Kulisevsky, J, Bergmans, B, Gomez-Esteban, JC, Kagi, G, Raw, J, Stefani, A, Warnecke, T, Jost, WH. A European Observational Study to Evaluate the Safety and the Effectiveness of Safinamide in Routine Clinical Practice: The SYNAPSES Trial (vol 11, pg 187, 2021). Journal of Parkinsons Disease. 2022; 12(1)DOI:10.3233/JPD-219007. PMID:34275911. IF:5.200(Q1/3D).
24/10/2025 Fatigue and neuropsychiatric symptoms in Parkinson's disease: a narrative review
Bojtos, L, Rodríguez-Antigüedad, J, Pagonabarraga, J, Martínez-Horta, S, Kulisevsky, J. Fatigue and neuropsychiatric symptoms in Parkinson's disease: a narrative review. Frontiers in Neurology. 2025; 16DOI:10.3389/fneur.2025.1670644. PMID:41211291. IF:2.800(Q2/5D).
01/10/2025 The role of endothelial dysfunction in the age-related poor prognosis of stroke patients undergoing endovascular treatment
de la Riva, P, Rodríguez-Antigüedad, J, Marta-Enguita, J, Gómez, V, Arenaza, G, Gorostidi, A, Díez, N, de Arce, A, Garmendia, E, Zumeta, E, Larrea, JA, Bergareche, A, Arregui, ALD. The role of endothelial dysfunction in the age-related poor prognosis of stroke patients undergoing endovascular treatment. Journal of Stroke & Cerebrovascular Diseases. 2025; 34(10)DOI:10.1016/j.jstrokecerebrovasdis.2025.108412. PMID:40769286. IF:1.800(Q3/7D).
01/09/2025 Correspondence to: Use of levodopa-carbidopa intestinal gel to treat patients with multiple system atrophy
Lopes, S, Fonseca, V, Pascual-Sedano, B, Simoes, R, Varanda, S, Pagonabarraga, J, Campolongo, A, Rodrigues, M. Correspondence to: Use of levodopa-carbidopa intestinal gel to treat patients with multiple system atrophy. PARKINSONISM & RELATED DISORDERS. 2025; 138DOI:10.1016/j.parkreldis.2025.107966. PMID:40763399. IF:3.400(Q2/3D).
25/08/2025 Restoration of CB1 receptor function in hippocampal GABAergic neurons rescues memory deficits in Huntington's disease models
Di Franco, N, de Tena, IB, Sanchez-Ruiz, A, Pereda-Velarde, A, Enfedaque, F, Gónzalez-Arias, C, Rio, LMM, Bortolozzi, A, Rodriguez-Puertas, R, Costas-Insua, C, Molina-Porcel, L, Vazquez-Oliver, A, Ozaita, A, Guzmán, M, Perea, G, Ginés, S. Restoration of CB1 receptor function in hippocampal GABAergic neurons rescues memory deficits in Huntington's disease models. Translational Neurodegeneration. 2025; 14(1)DOI:10.1186/s40035-025-00500-w. PMID:40855505. IF:15.200(Q1/1D).
20/08/2025 Parkinson's disease medication adjustments based on wearable device information compared to other methods: randomized clinical trial
Rodríguez-Molinero, A, Pérez-López, C, Caballol, N, Buongiorno, M, Rivera, MAA, Ariztegui, NL, López-Manzanares, L, Hernández-Vara, J, Bayes-Rusiñol, A, Carreró, AG, Saúco, MA, Gomez, EF, Pérez-Martínez, DA, Arroyo, SE, Martí-Martínez, S, Mir, P, Juan, JMS, Martínez-Castrillo, JC, Tebé, C. Parkinson's disease medication adjustments based on wearable device information compared to other methods: randomized clinical trial. npj Parkinsons Disease. 2025; 11(1)DOI:10.1038/s41531-025-00977-2. PMID:40835832. IF:8.200(Q1/1D).
11/08/2025 Expanding the clinical-radiological phenotype of SCA34 and its role in the differential diagnosis of the hot cross bun sign
Olmedo-Saura, G, Iruzubieta, P, Bernal, S, Gonzalez-Quereda, L, Pont-Sunyer, C, Navalpotro-Gómez, I, Guisado-Alonso, D, García-Sanchez, C, Rodriguez-Santiago, B, Brais, B, Pagonabarraga, J, Kulisevsky, J, Pérez-Pérez, J. Expanding the clinical-radiological phenotype of SCA34 and its role in the differential diagnosis of the hot cross bun sign. JOURNAL OF NEUROLOGY. 2025; 272(9)DOI:10.1007/s00415-025-13316-5. PMID:40788501. IF:4.600(Q1/2D).
01/08/2025 CSF Biomarker-Based Cognitive Trajectories in Parkinson's Disease-Subjective Cognitive Decline
Rodriguez-Antiguedad, J, Puig-Davi, A, Ruíz-Barrio, I, Pagonabarraga, J, Vázquez-Oliver, A, Horta-Barba, A, Kulisevsky, J, Martínez-Horta, S. CSF Biomarker-Based Cognitive Trajectories in Parkinson's Disease-Subjective Cognitive Decline. Annals of Clinical and Translational Neurology. 2025; 12(8)DOI:10.1002/acn3.70075. PMID:40501082. IF:3.900(Q1/3D).
01/08/2025 Alterations of NMDAR Subunits in the Cerebrospinal Fluid Across Neurodegenerative and Immunological Disorders
Escamilla, S, Pérez-González, R, Márquez-Marco, C, Camporesi, E, Brinkmalm, G, Padovani, A, Pilotto, A, Tolassi, C, Arici, D, Volonghi, I, Zetterberg, H, Blennow, K, Pérez-Pérez, J, Kulisevsky, J, Cuchillo-Ibáñez, I, Sáez-Valero, J. Alterations of NMDAR Subunits in the Cerebrospinal Fluid Across Neurodegenerative and Immunological Disorders. JOURNAL OF NEUROCHEMISTRY. 2025; 169(8)DOI:10.1111/jnc.70192. PMID:40823742. IF:4.000(Q2/3D).
01/07/2025 Carvedilol vs. propranolol for the prevention of decompensation and mortality in patients with compensated and decompensated cirrhosis
Fortea, JI, Alvarado-Tapias, E, Simbrunner, B, Ezcurra, I, Hernández-Gea, V, Aracil, C, Llop, E, Puente, A, Roig, C, Reiberger, T, García-Pagan, JC, Calleja, JL, Ferrero-Gregori, A, Mandorfer, M, Villanueva, C, Crespo, J. Carvedilol vs. propranolol for the prevention of decompensation and mortality in patients with compensated and decompensated cirrhosis. JOURNAL OF HEPATOLOGY. 2025; 83(1)DOI:10.1016/j.jhep.2024.12.017. PMID:39701300. IF:33.000(Q1/1D).
27/06/2025 Update on the Symptomatic Treatment of Huntington's Disease: From Pathophysiology to Clinical Practice
Olmedo-Saura, G, Bernardi, E, Bojtos, L, Martínez-Horta, S, Pagonabarraga, J, Kulisevsky, J, Pérez-Pérez, J. Update on the Symptomatic Treatment of Huntington's Disease: From Pathophysiology to Clinical Practice. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2025; 26(13)DOI:10.3390/ijms26136220. PMID:40650011. IF:4.900(Q1/3D).
01/06/2025 Dysphagia in Parkinsons disease. A 5-year follow-up study
Santos-García, D, Fonticoba, TD, Jesús, S, Cosgaya, M, Caldentey, JG, Caballol, N, Legarda, I, Vara, JH, Cabo, I, Manzanares, LL, Aramburu, IG, Rivera, MAA, Mayordomo, VG, Nogueira, V, García-Soto, JD, Borrué, C, Vila, BS, Sauco, MA, Vela, L, Escalante, S, Cubo, E, Mendoza, Z, Pareés, I, Alonso, PS, Losada, MGA, Ariztegui, NL, Gastón, I, Kulisevsky, J, Seijo, M, Valero, C, Redondo, RA, Ordás, C, Menendez-González, M, Mcafee, D, Martinez-Martin, P, Mir, P. Dysphagia in Parkinsons disease. A 5-year follow-up study. NEUROLOGICAL SCIENCES. 2025; 46(6)DOI:10.1007/s10072-025-08027-8. PMID:39969751. IF:2.400(Q3/6D).